Axillary Ultrasound is the Recommended Initial Test
For a painless axillary tissue overgrowth with an upper arm lipoma-like mass, axillary ultrasound (US) is the appropriate initial diagnostic test 1. The ultrasound should assess whether the masses are solid or cystic, evaluate nodal morphology if lymph nodes are present, and characterize the sonographic features of the lipoma-like lesion.
What the Ultrasound Should Assess
The axillary US evaluation should specifically look for:
- Solid versus cystic nature of the masses
- Lymph node characteristics if adenopathy is present (cortical thickness, fatty hilum preservation, shape)
- Lipoma confirmation - typical lipomas show hyperechoic, compressible, homogeneous appearance and require no further evaluation once confirmed 1
- Any suspicious features such as hypoechoic components, irregular margins, or heterogeneity that would warrant biopsy
Clinical Reasoning and Next Steps
The differential diagnosis for painless axillary masses includes normal variants (accessory breast tissue, ectopic breast tissue), benign lesions (lipomas, reactive adenopathy), and malignancies (lymphoma, metastatic disease) 1.
If the ultrasound confirms a typical lipoma appearance, no further imaging or biopsy is needed 1. However, if the upper arm mass shows concerning features on ultrasound (such as hypoechoic components, size >5 cm, or heterogeneity), MRI becomes the next appropriate step 2, 3, 4.
When to Consider Additional Imaging
MRI should be obtained if:
- The lipoma-like mass is >5 cm in diameter 3
- Ultrasound shows atypical features (heterogeneity, hypoechoic nodules, thick septations >2mm) 2, 3
- The mass is intramuscular or deep to fascia 2, 3
MRI features that distinguish benign lipomas from atypical lipomatous tumors (ALTs) include:
- Tumor location (ALTs are typically below deep fascia) 2
- Size >10 cm (91.7% of ALTs versus 51.4% of lipomas) 2
- Septal thickness >2mm (58% of ALTs versus 11.8% of lipomas) 2
- Contrast enhancement involving >1/3 of tumor volume (33.3% of ALTs versus 2% of lipomas) 2
Important Caveats
Do not obtain mammography, CT, or PET/CT as initial tests - these are not supported for evaluating palpable axillary masses without other clinical indications 1. Mammography may be added as a complementary test if there is concern for breast primary malignancy or personal history of breast cancer, but it is not the initial test 1.
Core needle biopsy is recommended if:
- MRI shows ≥4 high-risk features (intramuscular location, thick septations, nonfat nodules, heterogeneity, ill-defined margins) 3
- The mass is >5 cm with multiple suspicious MRI features 3
- Immunohistochemical staining for MDM2 and CDK4 may be needed if histopathology is indeterminate to exclude ALT 5, 6, 7